Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

(2010) John MS Bartlett et al.   LANCET ONCOLOGY

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast

(2010) Semir Vranic et al.   MODERN PATHOLOGY

Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer

(2010) M. Cuadros et al.   PATHOBIOLOGY

Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification

(2009) Cathy B. Moelans et al.   BREAST CANCER RESEARCH AND TREATMENT

Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer

(2009) Y. Zhang et al.   CANCER RESEARCH

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations

(2009) Guido Sauter et al.   JOURNAL OF CLINICAL ONCOLOGY

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis

(2009) Caterina Marchiò et al.   JOURNAL OF PATHOLOGY

Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response

(2009) Monica M Reinholz et al.   LANCET ONCOLOGY

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma

(2009) Uma Krishnamurti et al.   MODERN PATHOLOGY

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

(2009) I-Tien Yeh et al.   MODERN PATHOLOGY

Treatment of metastatic breast cancer: looking towards the future

(2008) Surabhi Amar et al.   BREAST CANCER RESEARCH AND TREATMENT

Cardiac Toxicity of ErbB2-Targeted Therapies: What Do We Know?

(2008) Edith A. Perez   Clinical Breast Cancer

Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing

(2008) Isabelle Vanden Bempt et al.   JOURNAL OF CLINICAL ONCOLOGY

Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors

(2008) Federico A Monzon et al.   MODERN PATHOLOGY